Antihemostatic Therapy and Endoscopic Biliary Sphincterotomy Induced Bleeding

• Conditions: Endoscopic Biliary Sphincterotomy; Bleeding

• Registration Number: NCT01098617
• Lead Sponsor: Yuksek Ihtisas Hospital

Brief Summary

The aim of the study is to observe the effects of antihemostatic therapy including nonsteroidal antiinflammatory, anticoagulant and antiaggregant therapy and other patient and procedure related factors on the risk of endoscopic biliary sphincterotomy induced bleeding.

Detailed Description

Not available

Study Timeline

• Status Verified: 2010-04
• Study Start: 2010-04
• Study First Submitted: 2010-04-01
• Study First Submitted QC: 2010-04-02
• Last Update Submitted: 2010-04-02
• Study First Posted: 2010-04-05
• Last Update Posted: 2010-04-05
• Primary Completion: 2010-11
• Study Completion: 2010-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 350

Inclusion Criteria

• Hospitalization
• Endoscopic sphincterotomy
• The patients whose warfarin treatment was stopped and INR was normalized prior to examination

Exclusion Criteria

• The patients who had undergone endoscopic cholangiography with no sphincterotomy
• Outpatient procedures

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Bleeding induced by endoscopic biliary sphincterotomy	3 months

Trial Locations

Locations (1)

Turkiye Yuksek Ihtisas Hospital; 🇹🇷 Ankara, Turkey